BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24988065)

  • 1. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
    Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M
    Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K; Mysliwiec M; Pawlak D
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
    Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y
    Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.
    Balta I; Balta S; Demirkol S; Mikhailidis DP; Celik T; Akhan M; Kurt O; Kurt YG; Aydin I; Kilic S
    Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
    Sabry HH; Sabry JH; Daifalla AEH; Akl EM; Hamed AM; Torky AAA
    Vasc Health Risk Manag; 2018; 14():145-152. PubMed ID: 30022835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.
    Elkamshoushi AAM; Hassan EM; El Abd AM; Hassan SZ; Maher AA
    Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
    Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
    Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
    Samouilidou E; Bountou E; Papandroulaki F; Papamanolis M; Papakostas D; Grapsa E
    Ther Apher Dial; 2018 Aug; 22(4):325-331. PubMed ID: 29368426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
    Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
    Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
    Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease.
    Lee HG; Choi HY; Bae JS
    Kidney Int; 2014 Dec; 86(6):1079-81. PubMed ID: 25427083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
    Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.